IBDEI0LQ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10131,1,4,0)
 ;;=4^H34.812
 ;;^UTILITY(U,$J,358.3,10131,2)
 ;;=^5005569
 ;;^UTILITY(U,$J,358.3,10132,0)
 ;;=H34.811^^44^501^15
 ;;^UTILITY(U,$J,358.3,10132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10132,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,10132,1,4,0)
 ;;=4^H34.811
 ;;^UTILITY(U,$J,358.3,10132,2)
 ;;=^5005568
 ;;^UTILITY(U,$J,358.3,10133,0)
 ;;=E11.321^^44^501^66
 ;;^UTILITY(U,$J,358.3,10133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10133,1,3,0)
 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10133,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,10133,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,10134,0)
 ;;=E11.329^^44^501^67
 ;;^UTILITY(U,$J,358.3,10134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10134,1,3,0)
 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10134,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,10134,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,10135,0)
 ;;=E11.331^^44^501^68
 ;;^UTILITY(U,$J,358.3,10135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10135,1,3,0)
 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10135,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,10135,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,10136,0)
 ;;=E11.339^^44^501^69
 ;;^UTILITY(U,$J,358.3,10136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10136,1,3,0)
 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10136,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,10136,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,10137,0)
 ;;=E11.351^^44^501^70
 ;;^UTILITY(U,$J,358.3,10137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10137,1,3,0)
 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10137,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,10137,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,10138,0)
 ;;=E11.359^^44^501^71
 ;;^UTILITY(U,$J,358.3,10138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10138,1,3,0)
 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10138,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,10138,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,10139,0)
 ;;=E11.341^^44^501^72
 ;;^UTILITY(U,$J,358.3,10139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10139,1,3,0)
 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10139,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,10139,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,10140,0)
 ;;=E11.349^^44^501^73
 ;;^UTILITY(U,$J,358.3,10140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10140,1,3,0)
 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10140,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,10140,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,10141,0)
 ;;=E11.9^^44^501^74
 ;;^UTILITY(U,$J,358.3,10141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10141,1,3,0)
 ;;=3^Type 2 DM w/o Complications
 ;;^UTILITY(U,$J,358.3,10141,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,10141,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,10142,0)
 ;;=H35.363^^44^501^18
 ;;^UTILITY(U,$J,358.3,10142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10142,1,3,0)
 ;;=3^Drusen of Macular,Bilateral
 ;;^UTILITY(U,$J,358.3,10142,1,4,0)
 ;;=4^H35.363
 ;;^UTILITY(U,$J,358.3,10142,2)
 ;;=^5005660
 ;;^UTILITY(U,$J,358.3,10143,0)
 ;;=H35.362^^44^501^19
 ;;^UTILITY(U,$J,358.3,10143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10143,1,3,0)
 ;;=3^Drusen of Macular,Left Eye
 ;;^UTILITY(U,$J,358.3,10143,1,4,0)
 ;;=4^H35.362
